LarkaDrin Capsules and Methylnaltrexone Subcutaneous
Determining the interaction of LarkaDrin Capsules and Methylnaltrexone Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acetaminophen / dichloralphenazone / isometheptene mucate
Brand name: Nodolor
Synonyms: n.a.
Generic Name: methylnaltrexone
Brand name: Relistor
Synonyms: Methylnaltrexone (Subcutaneous), Methylnaltrexone, Methylnaltrexone (oral/injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- LarkaDrin Capsules-Methylnaltrexone Tablets
- LarkaDrin Capsules-Methylphen Tablets
- LarkaDrin Capsules-Methylphenidate
- LarkaDrin Capsules-Methylphenidate CD Capsules
- LarkaDrin Capsules-Methylphenidate Chewable Tablets
- LarkaDrin Capsules-Methylphenidate Controlled-Release Tablets
- Methylnaltrexone Subcutaneous-Laronidase
- Methylnaltrexone Subcutaneous-Laronidase Intravenous
- Methylnaltrexone Subcutaneous-Larotrectinib
- Methylnaltrexone Subcutaneous-Larotrectinib Capsules
- Methylnaltrexone Subcutaneous-Larotrectinib Oral Solution
- Methylnaltrexone Subcutaneous-Larotrectinib Sulfate